These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33955162)

  • 21. Comparative pharmacokinetics and bioavailability of gemifloxacin administered as an intravenous 200 mg formulation or an oral 320 mg tablet.
    Kim MJ; Lim HS; Cho SH; Bae KS
    Clin Drug Investig; 2014 Mar; 34(3):195-201. PubMed ID: 24385283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open-Label Pivotal Study.
    Wang X; Zhang ZY; Powers D; Wang J; Lu S; Arora S; Hughes L; Christensen J; Kansra V
    J Clin Pharmacol; 2017 Dec; 57(12):1600-1606. PubMed ID: 28906561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies.
    Maekawa Y; Hasegawa S; Ishizuka T; Shiosakai K; Ishizuka H
    Adv Ther; 2019 Oct; 36(10):2930-2940. PubMed ID: 31399883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative bioequivalence study of two marketed formulation of betamethasone injectable suspensions.
    Zakeri-Milani P; Ghanbarzadeh S; Basmenji S; Valizadeh H
    Drug Res (Stuttg); 2013 Oct; 63(10):545-9. PubMed ID: 23780505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, open-label 3-way crossover study to investigate the relative bioavailability and bioequivalence of crushed sildenafil 20 mg tablets mixed with apple sauce, extemporaneously prepared suspension (EP), and intact sildenafil 20 mg tablets in healthy volunteers under fasting conditions.
    Gao X; Ndongo MN; Checchio TM; Cook J; Duncan B; LaBadie RR
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):74-80. PubMed ID: 27128005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects.
    Flesch G; Tudor D; Denouel J; Bonner J; Camisasca R
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):299-308. PubMed ID: 12875346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Bioequivalence Estimation of Two Formulations of Alfuzosin Extended-Release Tablets.
    Al Bawab AQ; Alkhalidi BA; Albarahmieh E; Qassim SMA; Al-Saifi MAD; Al-Saifi B; Ling J; Al-Qerem W
    Clin Pharmacol Drug Dev; 2020 Oct; 9(7):780-784. PubMed ID: 32770667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design).
    Hung NA; Costa FG; Hung CT; Rosenberg ME
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):610-620. PubMed ID: 32468719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.
    Genge A; Pattee GL; Sobue G; Aoki M; Yoshino H; Couratier P; Lunetta C; Petri S; Selness D; Bidani S; Hirai M; Sakata T; Salah A; Apple S; Wamil A; Kalin A; Jackson CE
    Muscle Nerve; 2023 Feb; 67(2):124-129. PubMed ID: 36504406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.
    Qureshi I; Lovegren M; Wirtz V; Larouche R; Tanguay M; Anderson MS; Hartmann S; Coric V; Berman RM
    Clin Pharmacol Drug Dev; 2020 May; 9(4):476-485. PubMed ID: 31610101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability, safety and tolerability of intravenous brivaracetam in healthy Japanese participants.
    Yamamoto J; Ikeda K; Stockis A
    Xenobiotica; 2022 Feb; 52(2):146-151. PubMed ID: 35293287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetic and bioequivalence evaluation of two formulations of morniflumate 350-mg tablets in healthy male subjects
.
    Lee H; Yim SV; Kim BH; Lee S
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):95-101. PubMed ID: 27841153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.
    Hammami MM; De Padua SJS; Hussein R; Al Gaai E; Khodr NA; Al-Swayeh R; Alvi SN; Binhashim N
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):78. PubMed ID: 29216899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning.
    Nakamaru Y; Kakubari M; Yoshida K; Akimoto M; Todorovic V; Greis T; Kondo K
    Clin Ther; 2020 Aug; 42(8):1467-1482.e4. PubMed ID: 32800532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
    Stark JG; Engelking D; McMahen R; Sikes C
    Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.